Clinical Trial Update: Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating decitabine, venetoclax, and ponatinib for Philadelphia chromosome-positive acute myeloid leukemia and related chronic myelogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Accelerated Phase Chronic Myelogenous Leukemia Bcr-abl1-positive
• Acute Myeloid Leukemia
• Blast Phase Chronic Myelogenous Leukemia Bcr-abl1-positive
• Myelogenous Leukemia Bcr-abl1 Positive
• Myelogenous Leukemia Bcr-abl1-positive

Drugs mentioned

• Dacogen (decitabine)
• Iclusig (ponatinib)
• Venclyxto (Venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING